Intramuscular Immunoglobulin for Measles Postexposure Prophylaxis
NEJM Evidence · 26.05.2026 · 5 (6)
DOI: 10.1056/evidpha2600093 ↗Kurz gefasst
Editorial in der Zeitschrift NEJM Evidence, erschienen am 26.05.2026. Verfasst von Angela Weil und 5 weiteren Autor:innen. Beteiligte Einrichtung: Utah Department of Health and Human Services, Salt Lake City, UT, USA. Hauptthemen laut MEDLINE: Measles, Post-Exposure Prophylaxis, Immunoglobulins. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural CDC HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Utah Department of Health and Human Services, Salt Lake City, UT, USA.
- Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, USA.
- Intermountain Health, Salt Lake City, UT, USA.
- Division of Pediatric Infectious Diseases, University of Utah, Salt Lake City, UT, USA.
- Bear River Health Department, Logan, UT, USA.
Förderung
- Intramural CDC HHS
Zitieren
APA
Weil, A., Jones, A., Mansfield, K., Pavia, A. T., White, A., & Nolen, L. D. (2026). Intramuscular Immunoglobulin for Measles Postexposure Prophylaxis. NEJM Evidence, 5(6). https://doi.org/10.1056/evidpha2600093
Vancouver
Weil A, Jones A, Mansfield K, Pavia AT, White A, Nolen LD. Intramuscular Immunoglobulin for Measles Postexposure Prophylaxis. NEJM Evidence. 2026;5(6). doi:10.1056/evidpha2600093
BibTeX
@article{Weil2026,
author = {Weil, Angela and Jones, Anna and Mansfield, Kelly and Pavia, Andrew T and White, Angie and Nolen, Leisha D},
title = {Intramuscular Immunoglobulin for Measles Postexposure Prophylaxis},
journal = {NEJM Evidence},
year = {2026},
volume = {5},
number = {6},
doi = {10.1056/evidpha2600093}
}
EUVIMED